Investigating blood clotting changes in meningioma surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the coagulation and platelet function changes that occur in patients undergoing surgical resection of meningiomas, which are generally benign tumors but can lead to thrombembolic complications. Blood samples will be collected from patients before and immediately after their tumor resection to assess these changes. A control group of patients undergoing glioma resection will also be included to compare the coagulation responses. The study seeks to uncover the molecular mechanisms behind the increased thrombosis risk associated with meningiomas.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients undergoing resection for meningioma or
* Patients undergoing resection for glioma or
* Healthy controls
* written consent for study participation

Exclusion Criteria:

\-

Where it's running

• University Hospital for Anaesthesiology and Intensive Care Medicine, Tuebingen
  Tübingen, Baden-Wurttemberg, Germany Recruiting

Study contacts

• Study coordinator: Michael Koeppen, MD
• Email: michael.koeppen@med.uni-tuebingen.de
• Phone: +4970712986935

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Surgery for M1a Stage Lung Cancer with Pleural Metastasis

  This study is testing if surgery to remove the main tumor can help people with M1a stage lung cancer that has spread to the pleura live longer and feel better.

  Recruiting Fudan University · Shanghai, Shanghai Municipality · NCT06547710

• Using 5-ALA to prevent tumor recurrence in desmoid tumor patients

  This study is testing if taking a medication called 5-ALA before surgery and using red light therapy afterward can help prevent desmoid tumors from coming back in patients who have had surgery to remove them.

  Recruiting at 2 sites Phase 2 Tel-Aviv Sourasky Medical Center · Tel Aviv, Israel and 1 other locations · NCT01898416

• Digital cognitive check after a stroke in people with severe disability

  This study tests how well a digital cognitive assessment app (TuCAN-App) can track recovery in adults who had a major stroke and were severely disabled.

  Recruiting University Hospital Tuebingen · Tübingen · NCT07885189

• Multi-peptide Vaccination and PSMAxCD3 Antibody Therapy for Prostate Cancer with Biochemical Recurrence

  This phase 2 trial tests whether a PSMA-targeted bispecific antibody (CC-1), a prostate cancer peptide vaccine (VAC-XS15-PC01), or both can be given safely and help control biochemical recurrence after local therapy in men with prostate cancer.

  Recruiting Phase 2 University Hospital Tuebingen · Heidelberg, Baden-Wurttemberg and 3 other locations · NCT07860047

• Detecting cardiac amyloidosis in people with severe aortic valve narrowing

  This study tests non-invasively whether imaging tests can find heart amyloidosis in patients with severe aortic stenosis who are being evaluated for valve replacement.

  Recruiting University Hospital Tuebingen · Tübingen · NCT07752732

• Low-thermal Argon Plasma Devitalization for CIN2 Treatment

  This study tests whether a low-thermal argon plasma treatment can heal CIN2 on the cervix better than a sham procedure or active surveillance in women aged 18–40.

  Recruiting University Hospital Tuebingen · Tübingen, Baden-Wurttemberg · NCT07730645

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.